Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics
Published on January 2, 2025
its national network, the Company’s ability to raise adequate capital to fund the Hope Therapeutics acquisitions, and the Company’s ability